SLNSW-Pembrolizumab versus Ipilimumab in Advanced Melan...-TN_cdi_proquest_journals_2119956334

Pembrolizumab versus Ipilimumab in Advanced Melanoma

Full title: Pembrolizumab versus Ipilimumab in Advanced Melanoma

Author/creator: KEYNOTE-006 investigators, Robert, Caroline, Schachter, Jacob, Long, Georgina V, Arance, Ana, Grob, Jean Jacques, Mortier, Laurent, Daud, Adil, Carlino, Matteo S, McNeil, Catriona, Lotem, Michal, Larkin, James, Lorigan, Paul, Neyns, Bart, Blank, Christian U, Hamid, Omid, Mateus, Christine, Shapira-Frommer, Ronnie, Kosh, Michele, Zhou, Honghong, Ibrahim, Nageatte, Ebbinghaus, Scot, Ribas, Antoni.

Call Numbers:

Record Identifier: TN_cdi_proquest_journals_2119956334

Language: English

Formats: Articles

Publishers: United States: Massachusetts Medical Society

Permalink: https://collection.sl.nsw.gov.au/record/TN_cdi_proquest_journals_2119956334

Articles

Articles

Export this record

Export selected records

  • Export to excel
  • Permalink

    • Export record to excel

    File type to download

    Beta version

    Record title

    Pembrolizumab versus Ipilimumab in Advanced Melanoma

    Record identifier

    TN_cdi_proquest_journals_2119956334

    Record permalink

    https://collection.sl.nsw.gov.au/record/TN_cdi_proquest_journals_2119956334

    Share

    Pembrolizumab versus Ipilimumab in Advanced Melanoma

    ACCESS
    https://collection.sl.nsw.gov.au/record/TN_cdi_proquest_journals_2119956334

    Pembrolizumab versus Ipilimumab in Advanced Melanoma

    Full title

    Pembrolizumab versus Ipilimumab in Advanced Melanoma

    Author / Creator

    KEYNOTE-006 investigators ; Robert, Caroline ; Schachter, Jacob ; Long, Georgina V ; Arance, Ana ; Grob, Jean Jacques ; Mortier, Laurent ; Daud, Adil ; Carlino, Matteo S ; McNeil, Catriona ; Lotem, Michal ; Larkin, James ; Lorigan, Paul ; Neyns, Bart ; Blank, Christian U ; Hamid, Omid ; Mateus, Christine ; Shapira-Frommer, Ronnie ; Kosh, Michele ; Zhou, Honghong ; Ibrahim, Nageatte ; Ebbinghaus, Scot ; Ribas, Antoni

    Publisher

    United States: Massachusetts Medical Society

    Journal title

    The New England journal of medicine, 2015, Vol.372 (26), p.2521-2532

    Record Identifier

    TN_cdi_proquest_journals_2119956334

    Language

    English

    Formats

    Articles

    Publication information

    Publisher

    Subjects

    Subjects and topics

    Adolescent Adult Aged Aged, 80 and over Antibodies, Monoclonal - adverse effects Antibodies, Monoclonal - therapeutic use Antibodies, Monoclonal, Humanized - adverse effects Antibodies, Monoclonal, Humanized - therapeutic use Antineoplastic Agents - adverse effects Antineoplastic Agents - therapeutic use Antitumor activity Apoptosis Body weight Cell death Chemotherapy Comparative analysis Dosage and administration Drug dosages Drug therapy Equity stake Fees & charges Female Humans Immune checkpoint inhibitors Immune system Immunotherapy Ipilimumab Laboratories Male Melanoma Melanoma - drug therapy Melanoma - mortality Middle Aged Monoclonal antibodies Mutation Patients PD-1 protein Pembrolizumab Prognosis Programmed Cell Death 1 Receptor - immunology Response rates Skin Neoplasms - drug therapy Skin Neoplasms - mortality Survival Analysis Toxicity Tumors Young Adult

    More information

    — SCOPE AND CONTENTS

    Contents

    — ALTERNATIVE TITLES

    Full title

    — AUTHORS, ARTISTS AND CONTRIBUTORS

    Author / Creator

    Identifiers

    — PRIMARY IDENTIFIERS

    Record Identifier

    TN_cdi_proquest_journals_2119956334

    Permalink

    https://collection.sl.nsw.gov.au/record/TN_cdi_proquest_journals_2119956334

    — OTHER IDENTIFIERS

    ISSN

    E-ISSN

    DOI

    How to access this item

    Online

    1 item

    How to access?

    Login with a Library card

    Full text available >

    About resource >

    View in old catalogue

    Connecting people and collections